GT Biopharma, Inc. short interest in 2025
In 2025, GT Biopharma, Inc.'s disclosed short interest ran from 11.20% of shares outstanding on 28 Feb 2025 to 19.85% on 31 Dec 2025, a change of +8.65 percentage points. The year's high was 19.85% on 31 Dec 2025 and its low 5.15% on 29 Aug 2025, averaging 11.19% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.72 days on 30 Jun 2025. Full history: GT Biopharma, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.20% (28 Feb 2025)
- End of year
- 19.85% (31 Dec 2025)
- Change
- +8.65 pp
- High
- 19.85% (31 Dec 2025)
- Low
- 5.15% (29 Aug 2025)
- Average
- 11.19%
- Highest days to cover
- 3.72 (30 Jun 2025)
- SEC filings marked
- 5
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Feb 2025 | 11.20% | 1.00 | 10-K filed |
| 30 May 2025 | 6.79% | 1.00 | 10-Q filed |
| 13 Jun 2025 | 9.85% | 3.22 | |
| 30 Jun 2025 | 13.82% | 3.72 | |
| 15 Jul 2025 | 12.24% | 1.95 | |
| 31 Jul 2025 | 12.63% | 3.57 | |
| 15 Aug 2025 | 7.34% | 3.47 | 10-Q filed |
| 29 Aug 2025 | 5.15% | 1.24 | |
| 15 Sep 2025 | 8.42% | 1.00 | |
| 30 Sep 2025 | 6.87% | 1.00 | |
| 14 Nov 2025 | 13.42% | 1.00 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 15.38% | 2.00 | |
| 15 Dec 2025 | 13.66% | 1.34 | |
| 31 Dec 2025 | 19.85% | 1.00 |
See also: GT Biopharma, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.